venBio Global Strategic Fund IV, L.P.
- SEC CIK
- 0001862109
In the past year, 1 open-market purchase filing worth $6.50M and no sales.
Current role at each company
- ATTO Attovia Therapeutics, Inc.10% Owneras of Aug 10, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $6.50M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$6.50M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists venBio Global Strategic Fund IV, L.P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 (view filing)4:12 PM ET | Aug 6 | 4 days | venBio Global Strategic Fund IV, L.P.10% Owner | PPurchase | +382.4K | $17.00 | +$6.50M | +10.1%4.18M after |